Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

CHAMPLIN, RICHARD E

One or more keywords matched the following items that are connected to CHAMPLIN, RICHARD E

Item Type	Name
Academic Article	5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.
Academic Article	Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines.
Academic Article	Altered gene expression in busulfan-resistant human myeloid leukemia.
Academic Article	Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.
Concept	Antineoplastic Agents, Alkylating
Academic Article	Feasibility of autologous hematopoietic stem cell transplant in patients aged =70 years with multiple myeloma.
Academic Article	The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan.
Academic Article	Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer.
Academic Article	Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Academic Article	Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Academic Article	Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.
Academic Article	Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Academic Article	Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion.
Academic Article	High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Academic Article	The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Academic Article	Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
Academic Article	Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
Academic Article	Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
Academic Article	Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Academic Article	Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
Academic Article	Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
Academic Article	Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.
Academic Article	Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
Academic Article	Melphalan-based autologous transplant in octogenarian multiple myeloma patients.
Academic Article	Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.

Search Criteria

Antineoplastic Agents Alkylating